ANGELA ROMAN: Open Payments
NPI 1235196023 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,303 in 13 payments from 11 companies in 2025. Trend: 2023 $754 · 2024 $950 · 2025 $1,303
Food & beverage: $1,303
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 2 | $275 |
| COLOPLAST CORP | 2 | $165 |
| Medtronic, Inc. | 1 | $135 |
| GENZYME CORPORATION | 1 | $126 |
| Alexion Pharmaceuticals, Inc. | 1 | $126 |
| Novo Nordisk Inc | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $113 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $105 |
| Eisai Inc. | 1 | $94 |
| Lilly USA, LLC | 1 | $24 |
Products named: EPIDIOLEX, Titan, SYMPLICITY G3, CERDELGA, Ozempic, UZEDY, CAPLYTA, Leqembi.
Industry payments across MI — which companies pay providers there.
